Final Prospectus · 424B4
SYNLOGIC INC
Final Prospectus
Company context
Synlogic is a biopharmaceutical company historically focused on advancing novel therapeutics to transform the care of serious disease in need of new treatment options.
Current securities
As-filed source
As filedOpen full document ↗